These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5941517)

  • 1. [New apparatus for the determination of the disintegration time of tablets and granules].
    Melandri M; De Giuli G
    Farmaco Prat; 1966 Feb; 21(2):69-76. PubMed ID: 5941517
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of Calcium Ions on the Disintegration of Enteric-Coated Solid Dosage Forms.
    Al-Gousous J; Langguth P
    J Pharm Sci; 2016 Feb; 105(2):509-511. PubMed ID: 26523769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of film formers and plasticizers on the stability of resistance and disintegration behavior. 4. Pharmaceutical-technological and analytical studies of gastric juice-resistant commercial preparations].
    Thoma K; Heckenmüller H
    Pharmazie; 1987 Dec; 42(12):837-41. PubMed ID: 3444846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid oral dosage forms.
    Helliwell M; Taylor D
    Prof Nurse; 1993 Feb; 8(5):313-7. PubMed ID: 8451252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of enteric-coated tablets and pellets by two in vitro dissolution methods and by scanning electron microscopy.
    Odegårdstuen LI; Bjerknes K; Sande SA; Waaler T
    Acta Pharm Nord; 1991; 3(3):163-70. PubMed ID: 1793511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DOSAGE FORMS FOR USE IN ORAL THERAPEUTICS.
    BERNSTEIN HB; SCHEINDLIN S
    J Oral Ther Pharmacol; 1964 Jul; 1():99-105. PubMed ID: 14204422
    [No Abstract]   [Full Text] [Related]  

  • 7. Tablets of coated aspirin microspherules--a new dosage form.
    Green DM
    J New Drugs; 1966; 6(5):294-304. PubMed ID: 5339421
    [No Abstract]   [Full Text] [Related]  

  • 8. [Resistance and disintegration behavior of gastric juice-resistant drug products. 3. Pharmaceutical-technological and analytical studies of gastric juice-resistant commercial preparations].
    Thoma K; Heckenmüller H; Oschmann R
    Pharmazie; 1987 Dec; 42(12):832-6. PubMed ID: 3444845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparatus, for tablet disintegration, and for shaking-out extractions.
    GERSHBERG S; STOLL FD
    J Am Pharm Assoc Am Pharm Assoc; 1946 Sep; 35(9):284-7. PubMed ID: 21002910
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
    Varum FJ; Hatton GB; Freire AC; Basit AW
    Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drugs in tablets].
    Borzunov EE
    Farm Zh; 1976; (4):17-21. PubMed ID: 793856
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lacquered tablets and film dragees].
    Hess H; Janssen HJ
    Pharm Acta Helv; 1969 Oct; 44(10):581-601. PubMed ID: 4901296
    [No Abstract]   [Full Text] [Related]  

  • 13. Disintegration of coated tablets -- unit-to-unit variation.
    Sandell E; Mellström G
    Acta Pharm Suec; 1975; 12(3):293-6. PubMed ID: 1163249
    [No Abstract]   [Full Text] [Related]  

  • 14. Aspirin.
    Scopp IW; Roehrl PL
    N Y J Dent; 1979; 49(7):218-20. PubMed ID: 287960
    [No Abstract]   [Full Text] [Related]  

  • 15. Apparatus for studying the disintegration of tablet coatings.
    Anderson W; Sakr A
    J Pharm Pharmacol; 1967 May; 19(5):329-31. PubMed ID: 4382406
    [No Abstract]   [Full Text] [Related]  

  • 16. Magnetic marker monitoring: high resolution real-time tracking of oral solid dosage forms in the gastrointestinal tract.
    Weitschies W; Blume H; Mönnikes H
    Eur J Pharm Biopharm; 2010 Jan; 74(1):93-101. PubMed ID: 19619649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The solubility kinetics of enteric-resistant tablets using riboflavin test tablets. 6. Pharmaceutic-technologic and analytic studies on gastric juice-resistant dosage forms].
    Thoma K; Oschmann R
    Pharmazie; 1991 May; 46(5):331-6. PubMed ID: 1896478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of compression forces on tablets disintegration by AC Biosusceptometry.
    Corá LA; Fonseca PR; Américo MF; Oliveira RB; Baffa O; Miranda JR
    Eur J Pharm Biopharm; 2008 May; 69(1):372-9. PubMed ID: 18164605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of disintegration of rapidly disintegrating tablets by a visiometric liquid jet-mediated disintegration apparatus.
    Desai PM; Liew CV; Heng PW
    Int J Pharm; 2013 Feb; 442(1-2):65-73. PubMed ID: 22985772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing gastrointestinal motility and disintegration profiles of magnetic tablets by a novel magnetic imaging device and gamma scintigraphy.
    Goodman K; Hodges LA; Band J; Stevens HN; Weitschies W; Wilson CG
    Eur J Pharm Biopharm; 2010 Jan; 74(1):84-92. PubMed ID: 19602377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.